Cost effectiveness of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in a Middle-Income Country, Turkey: Results of a Prospective Multicenter Study

OBJECTIVE: Breast cancer is a heterogenous disease, and genetic profiling helps to individualize adjuvant treatment. The Oncotype DX is a validated test to predict benefit of adjuvant systemic treatment. The aims of this study are to determine the costs of chemotherapy in government hospitals in Tur...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Breast Health
Main Authors: Özmen, Vahit, Çakar, Burcu, Gökmen, Erhan, Özdoğan, Mustafa, Güler, Nilufer, Uras, Cihan, Ok, Engin, Demircan, Orhan, Işıkdoğan, Abdurrahman, Saip, Pınar
Formato: Artigo
Idioma:Inglês
Publicado em: Turkish Federation of Breast Diseases Associations 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6619785/
https://ncbi.nlm.nih.gov/pubmed/31312795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/ejbh.2019.4761
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados